Pakdaman Consulting, Inc.
Claims Substantiation
SAE Reporting
Medical Writing / Manuscript Publication
Clinical Research Projects
Key Client Testimonials
“I-Health, Inc. has worked with Pakdaman Consulting for several years related to adverse event reporting. In our experience we have found the services to be reliable, with great attention to time sensitivities, details, and communication.”
​
- Julie Bagley (I-Health, Inc.)
“I have had the pleasure of working with Dr. Pakdaman for many years and each project is as well done as the one before. From the quoting process to the finished project, everything is always thorough, on time, easy to understand, and above expectation. He goes above and beyond, helping where he can, and I am happy to say he is our go to for product substantiation.”
​
- Charlie Foley (HealthPLUS, Inc.)
“Dr. Pakdaman helped us out in a tricky situation with another consulting firm that dropped the ball on our project. He is completely professional and competent, and we would highly recommend him.“
- Michael Shahani (Nebraska Cultures)
“Bayview Research has worked with Pakdaman Consulting since 2014 and could not be happier. Michael Pakdaman,M.D. has been a sub-investigator on numerous studies at our site. His expertise in clinical trials is wide ranging and includes studies in the following therapeutic areas: Neurology /Alzheimer's Disease, Mild Cognitive Impairment, Gynecology / Hot Flashes, Uterine Fibroids, Orthopedic / Osteoarthritis, Back Pain, Urology / Overactive Bladder, Metabolic / Diabetes, and Cardiology / Dyslipidemia. He has worked closely with clinical trial monitors from Amgen, Merck, Pfizer, Astellas, and a large array of other pharmaceutical & biotechnology companies. We have been extremely satisfied by the attention to detail and the efficiency that Dr. Pakdaman has provided to our site. We are more than pleased to have an ongoing working relationship with Pakdaman Consulting.
​
Dr. Pakdaman is great with clients, staff and patients as exemplified from attached patient communication report by study adjudication committee.”
- Michael Feist (Bayview Research Group)
